Prelude Therapeutics Announces First Quarter 2023 Financial

08.05.2023 - Eight abstracts presented at AACR 2023 demonstrate progress of the pipeline Cash runway unchanged, supporting operations into the fourth quarter of 2024 WILMINGTON, Del., May 08, 2023 (GLOBE NEWSWIRE) - Prelude Therapeutics Incorporated (Nasdaq: ...

Related Keywords

United States , American , Lindsey Trickett , Kris Vaddi , Helen Shik , American Association For Cancer Research Annual Meeting , Linkedin , Twitter , Shik Communications , Program Updates , Development Rd Expenses , Exchange Commission , Inhibitor Program , Protein Degrader Program , Chief Executive Officer , Cancer Research Annual Meeting , Next Generation , Protein Degrader , Cash Equivalents , Marketable Securities , Private Securities Litigation Reform Act , Months Ended March , Prelude Therapeutics ,